Recall Type: Drug Recall
Source: FDA Recall Notice
Recall Date: August 21, 2026
Summary: AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.
Read the original recall notice
Medication Ingredient Resources
Need to check medication ingredients or possible allergen concerns? Visit PillParser.com for ingredient lookup and RxAllergyScan.com to compare medications against an allergen profile.